|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yakirevich E and Resnick MB: Pathology of
gastric cancer and its precursor lesions. Gastroenterol Clin North
Am. 42:261–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oom AL, Humphries BA and Yang C:
MicroRNAs: Novel players in cancer diagnosis and therapies. Biomed
Res Int. 2014:9594612014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tong F, Cao P, Yin Y, Xia S, Lai R and Liu
S: MicroRNAs in gastric cancer: From benchtop to bedside. Dig Dis
Sci. 59:24–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan HW, Li SC and Tsai KW: MicroRNA
dysregulation in gastric cancer. Curr Pharm Des. 19:1273–1284.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim SY, Jeon TY, Choi CI, Kim DH, Kim DH,
Kim GH, Ryu DY, Lee BE and Kim HH: Validation of circulating miRNA
biomarkers for predicting lymph node metastasis in gastric cancer.
J Mol Diagn. 15:661–669. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Zheng Y, Sun G and Xiong S:
Restoration of miR-7 expression suppresses the growth of Lewis lung
cancer cells by modulating epidermal growth factor receptor
signaling. Oncol Rep. 32:2511–2516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Z, Jiang Z, Huang J, Huang S, Li Y, Yu
S, Yu S and Liu X: miR-7 inhibits glioblastoma growth by
simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK
pathways. Int J Oncol. 44:1571–1580. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Masuda M, Miki Y, Hata S, Takagi K,
Sakurai M, Ono K, Suzuki K, Yang Y, Abe E, Hirakawa H, et al: An
induction of microRNA, miR-7 through estrogen treatment in breast
carcinoma. J Transl Med. 10 Suppl 1:S22012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao X, Dou W, He L, Liang S, Tie J, Liu
C, Li T, Lu Y, Mo P, Shi Y, et al: MicroRNA-7 functions as an
anti-metastatic microRNA in gastric cancer by targeting
insulin-like growth factor-1 receptor. Oncogene. 32:1363–1372.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie J, Chen M, Zhou J, Mo MS, Zhu LH, Liu
YP, Gui QJ, Zhang L and Li GQ: miR-7 inhibits the invasion and
metastasis of gastric cancer cells by suppressing epidermal growth
factor receptor expression. Oncol Rep. 31:1715–1722. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kong D, Piao YS, Yamashita S, Oshima H,
Oguma K, Fushida S, Fujimura T, Minamoto T, Seno H, Yamada Y, et
al: Inflammation-induced repression of tumor suppressor miR-7 in
gastric tumor cells. Oncogene. 31:3949–3960. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao AG, Zhao HL, Jin XJ, Yang JK and Tang
LD: Effects of Chinese Jianpi herbs on cell apoptosis and related
gene expression in human gastric cancer grafted onto nude mice.
World J Gastroenterol. 8:792–796. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao AG, Yang JK, You SF, Li T, Zhao HL,
Gu Y, Tang LD and Qiu JX: Effects of Chinese herbal recipe
Weichang'an in inducing apoptosis and related gene expression in
human gastric cancer grafted onto nude mice. Zhong Xi Yi Jie He Xue
Bao. 5:287–297. 2007.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang WG, Ye L, Ji K, Frewer N, Ji J and
Mason MD: Inhibitory effects of Yangzheng Xiaoji on angiogenesis
and the role of the focal adhesion kinase pathway. Int J Oncol.
41:1635–1642. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Deng HX, Yu YY, Zhou AQ, Zhu JL, Luo LN,
Chen WQ, Hu L and Chen GX: Yangzheng sanjie decoction regulates
proliferation and apoptosis of gastric cancer cells by enhancing
let-7a expression. World J Gastroenterol. 23:5538–5548. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen GX and Li HG: Influences of Yangzheng
Sanjie Decoction on EGF EGFR of gastric mucosa at precancerosis of
chronic atrophic gastritis. Guiding J of TCM. 20–22. 2007.
|
|
24
|
Chen GX, Mou T and Li HG: 55 cases of
clinic observation for the precancerous lesions (chronic atrophic
gastritis) treatment on Yangzheng Sanjie Decoction. Gilin TCM.
1–18. 2007.
|
|
25
|
Iwama H, Amagaya S and Ogihara Y: Effect
of shosaikoto, a Japanese and Chinese traditional herbal medicinal
mixture, on the mitogenic activity of lipopolysaccharide: A new
pharmacological testing method. J Ethnopharmacol. 21:45–53. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lauren P: The two histological main types
of gastric carcinoma: diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Japanese Gastric Cancer Association, .
Japanese classification of gastric carcinoma-2nd English edition.
Gastric Cancer. 1:10–24. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ren M, Zhang J, Wang B, Liu P, Jiang H,
Liu G and Yin H: Qindan-capsule inhibits proliferation of
adventitial fibroblasts and collagen synthesis. J Ethnopharmacol.
129:53–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng F, Wu J, Li X, Tang Q, Yang L, Yang
X, Wu W and Hann SS: Chinese herbal medicine Fuzheng Kang-Ai
Decoction inhibited lung cancer cell growth through AMPKα-mediated
induction and interplay of IGFBP1 and FOXO3a. Evid Based Complement
Alternat Med. 2016:50607572016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iwama H, Amagaya S and Ogihara Y: Effect
of shosaikoto, a Japanese and Chinese traditional herbal medicinal
mixture, on the mitogenic activity of lipopolysaccharide: A new
pharmacological testing method. J Ethnopharmacol. 21:45–53. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yijing L, Liu H, Yuan C, Wang B, Ren M,
Yan L, Wang X and Zhang J: The effects of qindan-capsule-containing
serum on the TGF-β1/ERK signaling pathway, matrix metalloproteinase
synthesis and cell function in adventitial fibroblasts. Pharm Biol.
51:712–721. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang J, Yu JC, Kang WM and Ma ZQ:
Treatment strategy for early gastric cancer. Surg Oncol.
21:119–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Smalley SR, Benedetti JK, Haller DG,
Hundahl SA, Estes NC, Ajani JA, Gunderson LL, Goldman B, Martenson
JA, Jessup JM, et al: Updated analysis of SWOG-directed intergroup
study 0116: A phase III trial of adjuvant radiochemotherapy versus
observation after curative gastric cancer resection. J Clin Oncol.
30:2327–2333. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lordick F, Lorenzen S, Yamada Y and Ilson
D: Optimal chemotherapy for advanced gastric cancer: Is there a
global consensus? Gastric Cancer. 17:213–225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gordaliza M: Natural products as leads to
anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ji HF, Li XJ and Zhang HY: Natural
products and drug discovery. Can thousands of years of ancient
medical knowledge lead us to new and powerful drug combinations in
the fight against cancer and dementia? EMBO Rep. 10:194–200.
2009.PubMed/NCBI
|
|
38
|
Bian ZX, Xu H, Lu AP, Lee MS and Cheung H:
Insights of Chinese medicine syndrome study: From current status to
future prospects. Chin J Integr Med. 20:326–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lin J, Chen Y, Cai Q, Wei L, Zhan Y, Shen
A, Sferra TJ and Peng J: Scutellaria Barbata D Don inhibits
colorectal cancer growth via suppression of multiple signaling
pathways. Integr Cancer Ther. 13:240–248. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lee DH, Kim SS, Seong S, Woo CR and Han
JB: A case of metastatic bladder cancer in both lungs treated with
korean medicine therapy alone. Case Rep Oncol. 7:534–540. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J
and Sung JJ: MicroRNA dysregulation in gastric cancer: A new player
enters the game. Oncogene. 29:5761–5771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Link A, Kupcinskas J, Wex T and
Malfertheiner P: Macro-role of microRNA in gastric cancer. Dig Dis.
30:255–267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu HH, Lin WC and Tsai KW: Advances in
molecular biomarkers for gastric cancer: miRNAs as emerging novel
cancer markers. Expert Rev Mol Med. 16:e12014. View Article : Google Scholar : PubMed/NCBI
|
